Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 2 Comparison of clopidogrel pretreatment versus no pretreatment with respect to 30-day primary (death, myocardial infarction, urgent revascularization, and in-hospital major bleeding) and secondary (death, myocardial infarction, and urgent revascularization) end points in patients randomized to bivalirudin plus provisional glycoprotein (GP) IIb/IIIa blockade or heparin plus routine GP IIb/IIIa blockade.
|
